- Fund Type: SICAV
- Objective: Sector Fund-Health & Biotech
- Asset Class: Equity
- Geographic Focus: Global
Bellevue Funds Lux - BB Biotech
+ Add to WatchlistBBBIOUI:LX
280.39 USD 6.56 2.29%As of 08:52:00 ET on 05/16/2013.
Snapshot for Bellevue Funds Lux - BB Biotech (BBBIOUI)
| Year To Date: | +33.65% | 3-Month: | +23.46% | 3-Year: | +22.74% | 52-Week Range: | 183.58 - 289.62 |
|---|---|---|---|---|---|---|---|
| 1-Month: | +7.67% | 1-Year: | +45.27% | 5-Year: | - | Beta vs LUXXX: | 0.79 |
Fund Profile & Information for BBBIOUI
Bellevue Funds (Lux) - BB Biotech is an open-end investment fund incorporated in Luxembourg. The Fund's objective is long-term capital appreciation. The Fund invests mainly in equities and equity related securities of companies that are directly involved in the biotechnology sector. The focus is on companies that develop, research, and market various technologies and products in this sector.
| Inception Date: | 03-31-2009 | Telephone: | 41-44-267-67-00 |
|---|---|---|---|
| Managers: | DANIEL KOLLER / TAZIO STORNI | ||
| Web Site: | www.bellevuegroup.com | ||
Fundamentals for BBBIOUI
| NAV | (on 2013-05-16) 280.39 |
|---|---|
| Assets (M) | (on 2013-05-16) 28.09 |
| Fund Leveraged | N |
| Minimum Investment | 500,000.00 |
| Minimum Subsequent Investment | - |
Dividends for BBBIOUI
No dividends reported
Fees & Expenses for BBBIOUI
| Front Load | - |
|---|---|
| Back Load | 0.00 |
| Current Mgmt Fee | 0.90 |
| Redemption Fee | 0.00 |
| 12b1 Fee | - |
| Expense Ratio | - |
Top Fund Holdings for BBBIOUI
Filing Date: 04/30/2013| Name | Position | Value | % of Total |
|---|---|---|---|
| Gilead Sciences Inc | 44,976 | 2,277,585 | 8.948% |
| Celgene Corp | 18,702 | 2,208,145 | 8.676% |
| Biogen Idec Inc | 9,387 | 2,055,096 | 8.074% |
| Regeneron Pharmaceuticals Inc | 8,315 | 1,788,889 | 7.028% |
| Vertex Pharmaceuticals Inc | 18,371 | 1,411,260 | 5.545% |
| Alexion Pharmaceuticals Inc | 10,846 | 1,062,908 | 4.176% |
| Amgen Inc | 9,866 | 1,028,136 | 4.039% |
| Onyx Pharmaceuticals Inc | 9,017 | 854,812 | 3.358% |
| BioMarin Pharmaceutical Inc | 12,831 | 841,714 | 3.307% |
| Medivation Inc | 14,946 | 787,804 | 3.095% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page